PubMed:25406584
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 4-13 | SO:0001185 | denotes | enzymatic |
T2 | 15-20 | UBERON:0001977 | denotes | serum |
T3 | 26-32 | UBERON:0000479 | denotes | tissue |
T6 | 44-47 | SO:0002045 | denotes | pre |
T5 | 44-47 | PR:Q8LLD0 | denotes | pre |
T7 | 44-47 | UBERON:0001782 | denotes | pre |
T4 | 44-47 | GO:0003904 | denotes | pre |
T8 | 57-63 | UBERON:0000310 | denotes | breast |
T11 | 123-147 | D002285 | denotes | ductal carcinoma in situ |
T12 | 123-147 | D002285 | denotes | ductal carcinoma in situ |
T18 | 149-153 | CVCL_5552 | denotes | DCIS |
T17 | 149-153 | D002285 | denotes | DCIS |
T19 | 149-153 | D002285 | denotes | DCIS |
T20 | 174-187 | UBERON:2000098 | denotes | proliferation |
T21 | 246-252 | UBERON:0000310 | denotes | breast |
T22 | 253-257 | UBERON:0000025 | denotes | duct |
T23 | 253-257 | UBERON:0000058 | denotes | duct |
T25 | 293-310 | UBERON:0005769 | denotes | basement membrane |
T24 | 293-310 | GO:0005604 | denotes | basement membrane |
T30 | 318-322 | CVCL_5552 | denotes | DCIS |
T29 | 318-322 | D002285 | denotes | DCIS |
T31 | 318-322 | D002285 | denotes | DCIS |
T32 | 341-350 | PR:000000230 | denotes | precursor |
T33 | 341-350 | PR:000000291 | denotes | precursor |
T34 | 363-369 | UBERON:0000310 | denotes | breast |
T35 | 370-377 | D009369 | denotes | cancers |
T36 | 370-377 | D009369 | denotes | cancers |
T37 | 430-436 | 173331 | denotes | permit |
T39 | 561-565 | CVCL_5552 | denotes | DCIS |
T38 | 561-565 | D002285 | denotes | DCIS |
T40 | 561-565 | D002285 | denotes | DCIS |
T41 | 647-652 | D006801 | denotes | human |
T42 | 653-659 | UBERON:0000310 | denotes | breast |
T43 | 660-666 | UBERON:0000479 | denotes | tissue |
T44 | 699-708 | SO:0001185 | denotes | enzymatic |
T45 | 723-729 | UBERON:0000479 | denotes | tissue |
T46 | 739-745 | UBERON:0000310 | denotes | breast |
T47 | 746-752 | UBERON:0000479 | denotes | tissue |
T48 | 817-823 | UBERON:0000310 | denotes | breast |
T49 | 824-830 | UBERON:0000479 | denotes | tissue |
T51 | 893-897 | CVCL_5552 | denotes | DCIS |
T50 | 893-897 | D002285 | denotes | DCIS |
T52 | 893-897 | D002285 | denotes | DCIS |
T53 | 911-919 | CHEBI:33284 | denotes | nutrient |
T54 | 926-936 | D000900 | denotes | antibiotic |
T55 | 926-936 | D000900 | denotes | antibiotic |
T56 | 926-936 | CHEBI:33281 | denotes | antibiotic |
T57 | 949-954 | UBERON:0001977 | denotes | serum |
T58 | 991-997 | UBERON:0000479 | denotes | tissue |
T59 | 1022-1028 | UBERON:0000310 | denotes | breast |
T60 | 1029-1035 | UBERON:0000479 | denotes | tissue |
T61 | 1098-1104 | UBERON:0000310 | denotes | breast |
T62 | 1105-1111 | UBERON:0000479 | denotes | tissue |
T63 | 1165-1170 | UBERON:0001977 | denotes | serum |
T64 | 1211-1214 | PR:Q9VMJ7 | denotes | lid |
T65 | 1274-1284 | CL:0000057 | denotes | fibroblast |
T66 | 1397-1412 | CL:0000066 | denotes | epithelial cell |
T67 | 1537-1546 | SO:0001185 | denotes | enzymatic |
T68 | 1547-1553 | UBERON:0000479 | denotes | tissue |
T69 | 1649-1654 | D006801 | denotes | human |
T71 | 1655-1659 | CVCL_5552 | denotes | DCIS |
T70 | 1655-1659 | D002285 | denotes | DCIS |
T72 | 1655-1659 | D002285 | denotes | DCIS |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 363-377 | HP_0003002 | denotes | breast cancers |
T2 | 363-377 | HP_0100013 | denotes | breast cancers |
T3 | 370-377 | HP_0002664 | denotes | cancers |
T4 | 461-467 | HP_0002664 | denotes | cancer |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-115 | DRI_Background | denotes | Non-enzymatic, serum-free tissue culture of pre-invasive breast lesions for spontaneous generation of mammospheres. |
T2 | 116-311 | DRI_Background | denotes | Breast ductal carcinoma in situ (DCIS), by definition, is proliferation of neoplastic epithelial cells within the confines of the breast duct, without breaching the collagenous basement membrane. |
T3 | 312-488 | DRI_Background | denotes | While DCIS is a non-obligate precursor to invasive breast cancers, the molecular mechanisms and cell populations that permit progression to invasive cancer are not fully known. |
T4 | 489-730 | DRI_Challenge | denotes | To determine if progenitor cells capable of invasion existed within the DCIS cell population, we developed a methodology for collecting and culturing sterile human breast tissue at the time of surgery, without enzymatic disruption of tissue. |
T5 | 731-874 | DRI_Background | denotes | Sterile breast tissue containing ductal segments is harvested from surgically excised breast tissue following routine pathological examination. |
T6 | 875-1017 | DRI_Background | denotes | Tissue containing DCIS is placed in nutrient rich, antibiotic-containing, serum free medium, and transported to the tissue culture laboratory. |
T7 | 1018-1088 | DRI_Approach | denotes | The breast tissue is further dissected to isolate the calcified areas. |
T8 | 1089-1258 | DRI_Background | denotes | Multiple breast tissue pieces (organoids) are placed in a minimal volume of serum free medium in a flask with a removable lid and cultured in a humidified CO₂ incubator. |
T9 | 1259-1346 | DRI_Background | denotes | Epithelial and fibroblast cell populations emerge from the organoid after 10 - 14 days. |
T10 | 1347-1423 | DRI_Background | denotes | Mammospheres spontaneously form on and around the epithelial cell monolayer. |
T11 | 1424-1528 | DRI_Approach | denotes | Specific cell populations can be harvested directly from the flask without disrupting neighboring cells. |
T12 | 1529-1668 | DRI_Outcome | denotes | Our non-enzymatic tissue culture system reliably reveals cytogenetically abnormal, invasive progenitor cells from fresh human DCIS lesions. |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 116-311 | DRI_Background | denotes | Breast ductal carcinoma in situ (DCIS), by definition, is proliferation of neoplastic epithelial cells within the confines of the breast duct, without breaching the collagenous basement membrane. |
T2 | 312-488 | DRI_Background | denotes | While DCIS is a non-obligate precursor to invasive breast cancers, the molecular mechanisms and cell populations that permit progression to invasive cancer are not fully known. |
T3 | 489-730 | DRI_Challenge | denotes | To determine if progenitor cells capable of invasion existed within the DCIS cell population, we developed a methodology for collecting and culturing sterile human breast tissue at the time of surgery, without enzymatic disruption of tissue. |
T4 | 731-874 | DRI_Background | denotes | Sterile breast tissue containing ductal segments is harvested from surgically excised breast tissue following routine pathological examination. |
T5 | 875-1017 | DRI_Background | denotes | Tissue containing DCIS is placed in nutrient rich, antibiotic-containing, serum free medium, and transported to the tissue culture laboratory. |
T6 | 1018-1088 | DRI_Approach | denotes | The breast tissue is further dissected to isolate the calcified areas. |
T7 | 1089-1258 | DRI_Background | denotes | Multiple breast tissue pieces (organoids) are placed in a minimal volume of serum free medium in a flask with a removable lid and cultured in a humidified CO₂ incubator. |
T8 | 1259-1346 | DRI_Background | denotes | Epithelial and fibroblast cell populations emerge from the organoid after 10 - 14 days. |
T9 | 1347-1423 | DRI_Background | denotes | Mammospheres spontaneously form on and around the epithelial cell monolayer. |
T10 | 1424-1528 | DRI_Approach | denotes | Specific cell populations can be harvested directly from the flask without disrupting neighboring cells. |
T11 | 1529-1668 | DRI_Outcome | denotes | Our non-enzymatic tissue culture system reliably reveals cytogenetically abnormal, invasive progenitor cells from fresh human DCIS lesions. |